UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000028866
Receipt number R000033023
Scientific Title Association between total hemoglobin index measured using finger-mounted tissue oximetry and blood hemoglobin levels during puerperium: a prospective study
Date of disclosure of the study information 2017/08/28
Last modified on 2017/08/28 17:37:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association between total hemoglobin index measured using finger-mounted tissue oximetry and blood hemoglobin levels during puerperium: a prospective study

Acronym

Association between total hemoglobin index and blood hemoglobin levels during puerperium

Scientific Title

Association between total hemoglobin index measured using finger-mounted tissue oximetry and blood hemoglobin levels during puerperium: a prospective study

Scientific Title:Acronym

Association between total hemoglobin index and blood hemoglobin levels during puerperium

Region

Japan


Condition

Condition

Puerperium

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the association between the total hemoglobin index measured using finger-mounted tissue oximetry and blood hemoglobin levels during puerperium.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To calculate the correlation coefficient between the total hemoglobin index measured using finger-mounted tissue oximetry at the thenar muscle and blood hemoglobin levels during puerperium.

Key secondary outcomes

To calculate the correlation coefficient between the total hemoglobin index measured using finger-mounted tissue oximetry at deltoid and sternocleidomastoid muscles and blood hemoglobin levels during puerperium.
As an exploratory research, to investigate intra- and inter-rater reliabilities, a time-dependent change in values at the same objectives, and the association between tissue oxygen saturation and blood hemoglobin levels.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Finger-mounted tissue oximetry
For one day or two days

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. Women who are aged >19 years
2. Women who delivered in the past week, excluding the day of delivery
3. Women who have voluntarily provided written consent for participating in this study
4. Women whose hemoglobin levels were or will be measured along with hematological examination on the day of the study

Key exclusion criteria

1. Women who have malfunction in the circulatory and/or respiratory system: systolic blood pressure < 90 mmHg; pulse rate > 120/min; administration of a vasopressor; percutaneous oxygen saturation < 95%; administration of oxygen; presence of local circulatory dysfunction; active bleeding; and active diseases, such as acute heart failure and bronchial asthma
2. Body temperature > 38.0 degrees Celsius, body temperature < 35.0 degrees Celsius, and white blood cell count > 15000/mm3 or < 2000/mm3
3. Abnormal indoor condition or ambient temperature: ambient temperature > 30.0 degrees Celsius, ambient temperature < 10.0 degrees Celsius, or an abnormal weather
4. The interval between the measurement of the total hemoglobin index and hematological examination of >12 h
5. Women who have undergone transfusion in the past 16 weeks
6. A history of abnormal hemoglobinopathy
7. A body mass index of >30 or <18.5
8. Women who are evaluated to be ineligible for participating in the study by doctors

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshiyuki Uchida

Organization

Hamamatsu University School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan

TEL

053-435-2309

Email

utty@hama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kenta Kawai

Organization

Hamamatsu University School of Medicine

Division name

Department of Obstetrics and Gynecology

Zip code


Address

1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan

TEL

053-435-2309

Homepage URL


Email

D15018@hama-med.ac.jp


Sponsor or person

Institute

Hamamatsu University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Hamamatsu University School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 08 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 08 Month 28 Day

Date of IRB


Anticipated trial start date

2017 Year 09 Month 06 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 08 Month 28 Day

Last modified on

2017 Year 08 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033023


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name